Figure 1

Figure 2

Figure 3

Gene set linked to the eye injury caused by ionising radiation based on CTD and GeneMANIA analysis (http://ctdbase_org/; https://apps_cytoscape_org/apps/genemania)
| Gene symbol | Gene name | Gene ID |
|---|---|---|
| ATM | ATM serine/threonine kinase | 472 |
| CRYAB | Crystallin alpha B | 1410 |
| SIRT1 | Sirtuin 1 | 23411 |
| TGFB1 | Transforming growth factor beta 1 | 7040 |
| TREX1 | Three prime repair exonuclease 1 | 11277 |
| YAP1 | Yes1 associated transcriptional regulator | 10413 |
| TEAD2 | TEA domain transcription factor 2 | 8463 |
| RRP8 | Ribosomal RNA processing 8 | 23378 |
| CS | Citrate synthase | 1431 |
| TIPARP | TCDD inducible poly(ADP-ribose) polymerase | 25976 |
| CRYGC | Crystallin gamma C | 1420 |
| HIC1 | HIC ZBTB transcriptional repressor 1 | 3090 |
| EEF1E1 | Eukaryotic translation elongation factor 1 epsilon 1 | 9521 |
| LTBP4 | Latent transforming growth factor beta binding protein 4 | 8425 |
| NBN | Nibrin | 4683 |
| MSH2 | MutS homolog 2 | 4436 |
| WBP1 | WW domain binding protein 1 | 23559 |
| AMOTL1 | Angiomotin like 1 | 154810 |
| BMP3 | Bone morphogenetic protein 3 | 651 |
| LBH | LBH regulator of WNT signaling pathway | 81606 |
| CRYGS | Crystallin gamma S | 1427 |
| IFT20 | Intraflagellar transport 20 | 90410 |
| ITGB8 | Integrin subunit beta 8 | 3696 |
| FCN1 | Ficolin 1 | 2219 |
| CRYBB2 | Crystallin beta B2 | 1415 |
| ATR | ATR serine/threonine kinase | 545 |
Diseases and interacting genes associated with eye injury caused by radiation (CTD; http://ctdbase_org/)
| Phenotype | Disease | Gene |
|---|---|---|
| Cellular response to gamma radiation | Cataract | ATM | CRYAB |
| Cellular response to ionising radiation | Diabetic retinopathy | SIRT1 |
| Cellular response to ionising radiation | Retinal diseases | SIRT1 |
| Cellular response to gamma radiation | Coloboma, ocular, with or without hearing impairment, cleft lip/palate, and/or impaired intellectual development | YAP1 |
| Cellular response to gamma radiation | Cataract 16, multiple types | CRYAB |
| Regulation of cellular response to gamma radiation | Cataract | ATM |
| Cellular response to gamma radiation | Myopathy, myofibrillar, fatal infantile hypertonic, alpha-B crystallin-related | CRYAB |
| Cellular response to X-ray | Cataract | ATM |
| Cellular response to gamma radiation | Alpha-B crystallinopathy | CRYAB |
| Cellular response to ionising radiation | Dry eye syndromes | TGFB1 |
| Cellular response to ionising radiation | Cataract | ATM |
| Cellular response to gamma radiation | Vasculopathy, retinal, with cerebral leukodystrophy | TREX1 |
| Cellular response to ionising radiation | Graves disease | TGFB1 |
Top 15 gene ontology (molecular functions, biological processes) and molecular pathways associated with eye injury caused by ionising radiation (https://toppgene_cchmc_org)
| ID | Name | p-value | Input genes | Annotated genes | |
|---|---|---|---|---|---|
| Molecular functions | GO:0005212 | structural constituent of eye lens | 2.806E-8 | 4 | 25 |
| GO:0032405 | MutLalpha complex binding | 6.840E-8 | 3 | 7 | |
| GO:0032404 | mismatch repair complex binding | 3.214E-7 | 3 | 11 | |
| GO:0032407 | MutSalpha complex binding | 3.412E-5 | 2 | 7 | |
| GO:0044877 | protein-containing complex binding | 2.123E-4 | 9 | 1726 | |
| GO:0003950 | NAD+ ADP-ribosyltransferase activity | 6.938E-4 | 2 | 30 | |
| GO:0047485 | protein N-terminus binding | 7.323E-4 | 3 | 137 | |
| GO:0050699 | WW domain binding | 8.919E-4 | 2 | 34 | |
| GO:0004108 | citrate (Si)-synthase activity | 1.304E-3 | 1 | 1 | |
| GO:0160011 | NAD-dependent protein decrotonylase activity | 1.304E-3 | 1 | 1 | |
| GO:0160012 | NAD-dependent histone decrotonylase activity | 1.304E-3 | 1 | 1 | |
| GO:0036440 | citrate synthase activity | 1.304E-3 | 1 | 1 | |
| GO:0016763 | pentosyltransferase activity | 2.491E-3 | 2 | 57 | |
| GO:0106231 | protein-propionyllysine depropionylase activity | 2.603E-3 | 1 | 2 | |
| GO:0032129 | histone deacetylase activity (H3-K9 specific) | 2.603E-3 | 1 | 2 | |
| Biological processes | GO:0071479 | cellular response to ionising radiation | 1.415E-11 | 7 | 90 |
| GO:0042770 | signal transduction in response to DNA damage | 8.815E-11 | 8 | 200 | |
| GO:0010212 | response to ionising radiation | 9.545E-11 | 8 | 202 | |
| GO:0072331 | signal transduction by p53 class mediator | 9.545E-11 | 8 | 202 | |
| GO:0071480 | cellular response to gamma radiation | 5.615E-10 | 5 | 34 | |
| GO:0030330 | DNA damage response, signal transduction by p53 class mediator | 7.424E-10 | 6 | 83 | |
| GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator | 2.173E-9 | 5 | 44 | |
| GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator | 4.584E-9 | 4 | 17 | |
| GO:0097190 | apoptotic signaling pathway | 7.241E-9 | 10 | 715 | |
| GO:0071478 | cellular response to radiation | 8.951E-9 | 7 | 225 | |
| GO:0010332 | response to gamma radiation | 4.104E-8 | 5 | 78 | |
| GO:0009314 | response to radiation | 5.117E-8 | 9 | 646 | |
| GO:0045786 | negative regulation of cell cycle | 8.888E-8 | 8 | 483 | |
| GO:1901798 | positive regulation of signal transduction by p53 class mediator | 9.931E-8 | 4 | 35 | |
| GO:0097193 | intrinsic apoptotic signalling pathway | 2.361E-7 | 7 | 363 | |
| Cellular components | GO:0061773 | eNoSc complex | 4.112E-6 | 2 | 3 |
| GO:0140552 | TEAD-YAP complex | 4.112E-6 | 2 | 3 | |
| GO:0033553 | rDNA heterochromatin | 8.218E-6 | 2 | 4 | |
| GO:0000781 | chromosome, telomeric region | 4.993E-5 | 4 | 173 | |
| GO:0005677 | chromatin silencing complex | 1.237E-4 | 2 | 14 | |
| GO:0140513 | nuclear protein-containing complex | 1.424E-4 | 8 | 1386 | |
| GO:0016605 | PML body | 4.055E-4 | 3 | 122 | |
| GO:0098687 | chromosomal region | 1.439E-3 | 4 | 419 | |
| GO:0070310 | ATR-ATRIP complex | 2.389E-3 | 1 | 2 | |
| GO:0032301 | MutSalpha complex | 2.389E-3 | 1 | 2 | |
| GO:0034686 | integrin alphav-beta8 complex | 2.389E-3 | 1 | 2 | |
| GO:0032302 | MutSbeta complex | 2.389E-3 | 1 | 2 | |
| GO:0099126 | transforming growth factor beta complex | 3.582E-3 | 1 | 3 | |
| GO:1902636 | kinociliary basal body | 3.582E-3 | 1 | 3 | |
| GO:0005657 | replication fork | 3.703E-3 | 2 | 76 | |
| Molecular pathways | M9703 | role of BRCA1, BRCA2 and ATR in Cancer Susceptibility | 3.010E-8 | 4 | 22 |
| M39490 | DNA IR-damage and cellular response via ATR | 1.245E-7 | 5 | 81 | |
| M39598 | DNA IR-double strand breaks and cellular response via ATM | 1.358E-6 | 4 | 55 | |
| M648 | cell Cycle: G1/S Check Point | 1.012E-5 | 3 | 28 | |
| 137959 | BARD1 signalling events | 1.128E-5 | 3 | 29 | |
| M258 | BARD1 signalling events | 1.128E-5 | 3 | 29 | |
| 1270252 | molecules associated with elastic fibres | 1.384E-5 | 3 | 31 | |
| 1309108 | HDR through Single Strand Annealing (SSA) | 2.580E-5 | 3 | 38 | |
| 1309104 | presynaptic phase of homologous DNA pairing and strand exchange | 3.016E-5 | 3 | 40 | |
| M40049 | DNA repair pathways, full network | 3.166E-5 | 4 | 121 | |
| 1309097 | sensing of DNA Double Strand Breaks | 3.389E-5 | 2 | 6 | |
| 1270251 | elastic fibre formation | 3.497E-5 | 3 | 42 | |
| 1309103 | homologous DNA Pairing and Strand Exchange | 3.756E-5 | 3 | 43 | |
| M39628 | integrated cancer pathway | 4.310E-5 | 3 | 45 | |
| M39518 | ATM signalling in development and disease | 4.606E-5 | 3 | 46 |
Gene ontology terms linked to the obtained MCODE network [Metascape software (https://metascape_org)]
| GO | Description | Log10(P) |
|---|---|---|
| GO:0010212 | response to ionising radiation | −10.5 |
| GO:0071479 | cellular response to ionising radiation | −10.4 |
| GO:0071480 | cellular response to gamma radiation | −10.4 |
| GO:0000077 | DNA damage checkpoint signalling | −12.3 |
| GO:0031570 | DNA integrity checkpoint signalling | −12.2 |
| GO:0042770 | signal transduction in response to DNA damage | −11.7 |
miRNAs linked to eye injury caused by ionising radiation (https://toppgene_cchmc_org)
| ID | Name | pValue | Input genes | Annotated genes |
|---|---|---|---|---|
| hsa-miR-892b:mirSVR lowEffct | hsa-miR-892b:mirSVR non-conserved low effect-0.1-0.5 | 2.811E-7 | 8 | 1596 |
| hsa-miR-183:mirSVR highEffct | hsa-miR-183:mirSVR conserved high effect-0.5 | 1.597E-6 | 6 | 853 |
| hsa-miR-708:mirSVR lowEffct | hsa-miR-708:mirSVR non-conserved low effect-0.1-0.5 | 1.629E-6 | 7 | 1376 |
| hsa-miR-3688-3p | 2.792E-6 | 6 | 940 | |
| hsa-miR-3118:mirSVR lowEffct | hsa-miR-3118:mirSVR non-conserved low effect-0.1-0.5 | 4.640E-6 | 7 | 1613 |
| hsa-miR-19a-3p | 6.859E-6 | 6 | 1100 | |
| hsa-miR-19b-3p | 7.002E-6 | 6 | 1104 | |
| hsa-miR-590-5p | 1.105E-5 | 4 | 317 | |
| hsa-miR-3166:mirSVR lowEffct | hsa-miR-3166:mirSVR non-conserved low effect-0.1-0.5 | 1.146E-5 | 7 | 1853 |
| hsa-miR-589:mirSVR highEffct | hsa-miR-589:mirSVR non-conserved high effect-0.5 | 1.182E-5 | 7 | 1862 |
| hsa-miR-548ap-3p | 1.281E-5 | 6 | 1228 | |
| hsa-miR-548t-3p | 1.281E-5 | 6 | 1228 | |
| hsa-miR-548aa | 1.281E-5 | 6 | 1228 | |
| hsa-miR-21-5p | 1.455E-5 | 4 | 340 | |
| hsa-miR-19b:PITA | hsa-miR-19b:PITA TOP | 1.615E-5 | 5 | 741 |